Department of Adult Neurology, Medical University of Gdańsk, ul, Dębinki 7, 80-952, Gdańsk, Poland.
Department of Hypertension and Diabetology, Medical University of Gdańsk, ul, Dębinki 7, 80-952, Gdańsk, Poland.
Curr Hypertens Rep. 2020 Dec 10;23(1):3. doi: 10.1007/s11906-020-01120-7.
Abrupt blood pressure (BP) rise is the most common clinical symptom of acute ischemic stroke (AIS). However, BP alterations during AIS reflect many diverse mechanisms, both stroke-related and nonspecific epiphenomena, which change over time and across patients. While extremes of BP as well as high BP variability have been related with worse outcomes in observational studies, optimal BP management after AIS remains challenging.
This review discusses the complexity of the factors linking BP changes to the clinical outcomes of patients with AIS, depending on the treatment strategy and local vessel status and, in particular, the degree of reperfusion achieved. The evidence for possible additional clinical markers, including the presence of arterial hypertension, and comorbid organ dysfunction in individuals with AIS, as informative and helpful factors in therapeutic decision-making concerning BP will be reviewed, as well as recent data on neurovascular monitoring targeting person-specific local cerebral perfusion and metabolic demand, instead of the global traditional parameters (BP among others) alone. The individualization of BP management protocols based on a complex evaluation of the homeostatic response to focal cerebral ischemia, including but not limited to BP changes, may be a valuable novel goal proposed in AIS, but further trials are warranted.
目的综述:急性缺血性脑卒中(AIS)患者最常见的临床症状是血压(BP)突然升高。然而,AIS 期间的血压变化反映了许多不同的机制,既有与中风相关的机制,也有非特异性的伴随现象,这些机制会随着时间的推移和患者的不同而变化。虽然极端的血压和血压变异性与观察性研究中的不良结局有关,但 AIS 后的最佳血压管理仍然具有挑战性。
最新发现:本综述讨论了将血压变化与 AIS 患者临床结局联系起来的因素的复杂性,这取决于治疗策略以及局部血管状况,特别是达到的再灌注程度。本文还将回顾可能的其他临床标志物的证据,包括 AIS 患者的动脉高血压和合并器官功能障碍的存在,以及针对个体特定局部脑灌注和代谢需求的神经血管监测的最新数据,而不仅仅是传统的全局参数(包括血压)。基于对局部脑缺血的稳态反应的复杂评估,对 AIS 患者的血压管理方案进行个体化,可能是一个有价值的新目标,但需要进一步的试验。